Grace Callander

FTC Reaches Second Insulin Pricing Settlement: Comparing The Caremark And ESI Orders

Federal And State Policymakers Push Forward With PBM And Drug Pricing Reform Even In The Wake Of Sweeping Actions Earlier This Year

Congress Seeks Answers On Most-Favored-Nation Drug Pricing Agreements And Their Impact On Medicaid

Understanding California SB-41: What PBMs Operating In California Need To Know

The BALANCE Model And A New Wave Of CMS Drug Pricing Models

Pharmaceutical Policy In Motion: Updates On The Trump Administration's Drug Pricing Initiatives

Filling The Gaps And Navigating Fine Lines: Regulatory Compliance Framework And Considerations For California Medical Spas